Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors Company Close Updates

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. /zigman2/quotes/201549545/composite CRBP +10.81% slid 1.07% to $0.42 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.19% rising 1.28% to 14,194.45 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.95% rising 1.06% to 35,462.78. Corbus Pharmaceuticals Holdings Inc. closed $3.58 short of its 52-week high ($4.00), which the company reached on February 11th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Fate Therapeutics Inc. /zigman2/quotes/209623007/composite FATE +1.62% fell 0.30% to $39.55, Vanda Pharmaceuticals Inc. /zigman2/quotes/200957783/composite VNDA +1.76% rose 1.11% to $13.20, and Viking Therapeutics Inc. /zigman2/quotes/204618964/composite VKTX -0.34% fell 1.10% to $3.59. Trading volume (718,936) remained 374,570 below its 50-day average volume of 1.1 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

/zigman2/quotes/201549545/composite